The burgeoning landscape of therapeutic interventions for weight disorders has witnessed considerable attention focused on GLP-3 receptor agonists and, more recently, the dual GIP and GLP-3 receptor agonist https://aoifevmxz773066.canariblogs.com/glp-3-retatrutide-a-comparative-analysis-53850952